Craft

Smith & Nephew

Stock Price

$28.9

2024-10-29

Market Capitalization

$13.4 B

2024-08-26

Revenue

$5.8 B

FY, 2024

Smith & Nephew Summary

Company Summary

Overview
Smith & Nephew is a medical technology company. It operates through three main segments: Orthopaedics, Sports Medicine and Ear, Nose, and Throat (ENT), and Advanced Wound Management. Orthopaedics includes hip and knee implants to replace diseased, damaged, or worn joints, as well as robotics-assisted and digital enabling technologies; Sports Medicine and ENT segment offers products and instruments to repair or remove soft tissues; and Advanced Wound Management provides products and services for clinical needs.
Type
Public
Status
Active
Founded
1856
HQ
Watford, GB | view all locations
Website
https://www.smith-nephew.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Deepak Nath

    Deepak Nath, Chief Executive Officer

    • Brad Cannon

      Brad Cannon, President, Global Orthopaedics

      • Anne-Françoise Nesmes

        Anne-Françoise Nesmes, Chief Financial Officer and Director

      • Elga Lohler

        Elga Lohler, Chief Human Resources Officer

        Operating MetricsView all

        Countries

        100

        FY, 2022

        Sectors

        6

        FY, 2022

        LocationsView all

        57 locations detected

        • Watford, England HQ

          United Kingdom

          Building 5, Croxley Park Hatters Lane

        • Andover, MA

          United States

          150 Minuteman Rd

        • Austin, TX

          United States

          7000 W William Cannon Dr

        • Columbia, MD

          United States

          7015 Albert Einstein Dr

        • Fort Worth, TX

          United States

          5600 Clearfork Main St Suite 600

        • Memphis, TN

          United States

          1450 Brooks Road

        and 51 others

        Smith & Nephew Financials

        Summary Financials

        Revenue (FY, 2024)
        $5.8B
        Gross profit (FY, 2024)
        $4.7B
        Net income (FY, 2024)
        $412.0M
        Cash (FY, 2024)
        $619.0M
        EBIT (FY, 2024)
        $647.0M
        Enterprise value
        $16.1B

        Footer menu